0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Emergent BioSolutions, Inc. - logo

Emergent BioSolutions manufactures immunobiotics such as vaccines and immune globulins that assist the body’s immune system. The company’s biodefense segment develops drugs such as BioThrax, a vaccine for the prevention of anthrax, for use against biological agents. Other products in preclinical development include drugs for the treatment of patients exposed to anthrax and botulinum toxin. The company, which was founded in 1998, is based in Rockville, Maryland.

Anthrax - Pipeline Insight, 2024 - Product Thumbnail Image

Anthrax - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
EUR$1,500USDGBP
Chikungunya - Pipeline Insight, 2024 - Product Thumbnail Image

Chikungunya - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Marburg virus disease - Pipeline Insight, 2024 - Product Thumbnail Image

Marburg virus disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
EUR$1,500USDGBP
EUR$3,400USDGBP
Antibiotic Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Antibiotic Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 100 Pages
  • Global
From
EUR$3,995USDGBP
From
EUR$800USDGBP
From
EUR$4,750USDGBP
From
EUR$2,500USDGBP
From
EUR$4,000USDGBP
Leukemia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Leukemia Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 193 Pages
  • Global
From
EUR$4,950USDGBP
From
EUR$2,000USDGBP
From
EUR$4,200USDGBP
From
EUR$2,999USDGBP
From
EUR$3,995USDGBP
Loading Indicator
This website uses cookies to ensure you get the best experience. Learn more